Disease: Bone Resorption ×
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0005974
Disease: Bone Resorption
Bone Resorption 		0.300 Biomarker phenotype CTD_human RANKL targeted peptides inhibit osteoclastogenesis and attenuate adjuvant induced arthritis by inhibiting NF-κB activation and down regulating inflammatory cytokines. 23333834 2013
CUI: C0005974
Disease: Bone Resorption
Bone Resorption 		0.300 Therapeutic phenotype CTD_human RANKL targeted peptides inhibit osteoclastogenesis and attenuate adjuvant induced arthritis by inhibiting NF-κB activation and down regulating inflammatory cytokines. 23333834 2013
CUI: C0005974
Disease: Bone Resorption
Bone Resorption 		0.300 Therapeutic phenotype CTD_human Zoledronate reverses mandibular bone loss in osteoprotegerin-deficient mice. 18496637 2009
CUI: C0005974
Disease: Bone Resorption
Bone Resorption 		0.300 Biomarker phenotype CTD_human Zoledronate reverses mandibular bone loss in osteoprotegerin-deficient mice. 18496637 2009
CUI: C0005974
Disease: Bone Resorption
Bone Resorption 		0.300 Biomarker phenotype CTD_human The inhibition of RANKL causes greater suppression of bone resorption and hypercalcemia compared with bisphosphonates in two models of humoral hypercalcemia of malignancy. 15845617 2005
CUI: C0005974
Disease: Bone Resorption
Bone Resorption 		0.300 Therapeutic phenotype CTD_human The inhibition of RANKL causes greater suppression of bone resorption and hypercalcemia compared with bisphosphonates in two models of humoral hypercalcemia of malignancy. 15845617 2005